Acelrx Pharmaceuticals Inc

-0.02 (-1.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)117.02M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.9 Million
Adjusted EPS-$0.07
See more estimates
10-Day MA$1.00
50-Day MA$1.04
200-Day MA$1.45
See more pivots

Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX

25821 Industrial Boulevard, Suite 400, Hayward, California 94545
United States of America
Phone: +1.650.216.3500
Number of Employees: 54


AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.